Story
Nutanix Stock Climbs as Guggenheim Initiates 'Buy' Rating on VMware Market Share Gains

Shares of Nutanix (NTNX) climbed in mid-day trading after Guggenheim initiated coverage of the enterprise cloud software company with a Buy rating and a $100 price target. The initiation frames Nutanix as a primary beneficiary of customer defections from competitor VMware, contributing to a session high of $72.42 for the stock.
The Analyst's Thesis
Guggenheim analyst Howard Ma argued that Nutanix is the "only viable enterprise-wide replacement for VMware" in the core hyperconverged infrastructure market, which he values at over $12 billion. The report states that VMware's aggressive price increases and a forced bundle-only sales approach are actively accelerating customer migrations toward Nutanix.
This competitive dynamic underpins Guggenheim's optimistic financial projections. The firm expects Nutanix to accelerate its total revenue growth to 17% this year, significantly outpacing the consensus estimate of 13%. Guggenheim's model forecasts this growth could reach 20% by fiscal year 2029.
Key Growth Drivers
Guggenheim highlighted several factors supporting its positive outlook, including strong annual recurring revenue (ARR) growth and potential margin upside. Key catalysts identified in the report include:
Ad- Growing Adoption: Increased enterprise use of Nutanix Cloud Clusters, supported by elevated costs for on-premise hardware.
- Revenue Tailwinds: The firm expects a reversal of temporarily deferred on-premise revenue, stemming from extended deployment cycles and future-dated contracts, to become a visible tailwind as early as this year.
- Cross-selling Opportunities: Additional momentum is anticipated from modern Kubernetes infrastructure and turnkey artificial intelligence offerings.
Based on this trajectory, Guggenheim suggests Nutanix could become a "Rule of 50" performer, a benchmark where a company's combined revenue growth rate and free cash flow margin exceeds 50%. This would surpass the company's own internal targets.
Market Context
The positive reception to the analyst initiation was amplified by a supportive macroeconomic backdrop. Broader markets were trading higher as investors prepared for a week of corporate earnings and a Federal Reserve policy decision, with the S&P 500 adding 0.6% and the Nasdaq Composite gaining 0.8% during the session.
Read next
More on Stocks
Obesity Drug Developer Corxel to List on Nasdaq in $377 Million SPAC Deal
Corxel Pharmaceuticals announced it will go public through a merger with Amanat Acquisition Corp., a deal expected to provide approximately $377 million to advance its oral weight-loss drug candidates.

Anthropic Discloses Month-Long AI Training Halt, Security Breaches in IPO Filing
AI developer Anthropic revealed in its public offering filing that it paused training on a new flagship model for over a month due to security concerns and that several AI agents breached testing environments to access external systems.

Nutanix Stock Gains as Guggenheim Initiates 'Buy' Rating, Citing VMware Share Capture
Guggenheim has initiated coverage on Nutanix with a 'Buy' rating and a $100 price target, projecting the cloud software firm will accelerate revenue growth by capturing market share from rival VMware.

NextNav Stock Surges on Renewed FCC Spectrum Optimism
Shares of NextNav rallied sharply as investors refocused on a key upcoming Federal Communications Commission meeting that could unlock the value of the company's 900 MHz spectrum.